Chen Cheng, Li Shouqiang, Matsunaga Terry O, Pacella John J, Everbach E Carr, Xie Feng, Porter Thomas R, Villanueva Flordeliza S, Chen Xucai
Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh, Pittsburgh, PA, USA.
Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Ultrasound Med Biol. 2025 Feb;51(2):336-340. doi: 10.1016/j.ultrasmedbio.2024.10.012. Epub 2024 Nov 10.
Perfluoropropane droplets (PD) are nanometer-sized particles that can be formulated from commercially available contrast agents. The preferential retention of PDs in diseased microvascular beds can be detected by ultrasound imaging techniques after acoustic activation and offers an opportunity for the detection of such processes as scar formation or inflammation. We hypothesized that in the presence of ischemia/reperfusion (I/R) injury, retention of intravenously injected PDs would be enhanced.
Using an established intravital microscopy model of rat cremaster microcirculation, we determined the retention and subsequent acoustic activation behavior of PDs in exteriorized rat cremaster tissue. DiI-labeled droplets (200 µL) were administered intravenously. Acoustic activation was achieved with a clinical ultrasound system at two ultrasound frequencies (1.5 and 7 MHz).
Fluorescent microbubbles could be detected in the microvasculature after intravenous injection of PDs and subsequent acoustic activation. Increased retention of PDs was observed in the I/R group compared with control group with both ultrasound frequencies (p < 0.05). Using higher-resolution microscopy, we found evidence that some droplets extravasate to the outside of the endothelial border or are potentially engulfed by leukocytes.
Our data indicate that targeted imaging of the developing scar zones might be possible with ultrasound activation of intravenously injected PDs, and a method of targeting therapies to these same regions could be developed.
全氟丙烷微滴(PD)是纳米级颗粒,可由市售造影剂配制而成。声学激活后,通过超声成像技术可检测到PD在病变微血管床中的优先滞留,这为检测诸如瘢痕形成或炎症等过程提供了机会。我们假设在存在缺血/再灌注(I/R)损伤的情况下,静脉注射的PD的滞留会增强。
使用已建立的大鼠提睾肌微循环活体显微镜模型,我们确定了PD在大鼠体外提睾肌组织中的滞留及随后的声学激活行为。静脉注射DiI标记的微滴(200μL)。使用临床超声系统在两个超声频率(1.5和7MHz)下进行声学激活。
静脉注射PD并随后进行声学激活后,在微血管中可检测到荧光微泡。与对照组相比,在两个超声频率下,I/R组中PD的滞留均增加(p<0.05)。使用高分辨率显微镜,我们发现有证据表明一些微滴渗出到内皮边界之外或可能被白细胞吞噬。
我们的数据表明,通过静脉注射PD的超声激活,可能对正在形成的瘢痕区域进行靶向成像,并且可以开发一种将治疗靶向这些相同区域的方法。